DK1489090T3 - Hidtil ukendte pseudoerythromycinderivater - Google Patents
Hidtil ukendte pseudoerythromycinderivaterInfo
- Publication number
- DK1489090T3 DK1489090T3 DK04022619T DK04022619T DK1489090T3 DK 1489090 T3 DK1489090 T3 DK 1489090T3 DK 04022619 T DK04022619 T DK 04022619T DK 04022619 T DK04022619 T DK 04022619T DK 1489090 T3 DK1489090 T3 DK 1489090T3
- Authority
- DK
- Denmark
- Prior art keywords
- hitherto unknown
- derivatives
- pseudoerythromycin
- pseudoerythromycin derivatives
- psedoerythromycin
- Prior art date
Links
- 125000002252 acyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000000304 alkynyl group Chemical group 0.000 abstract 1
- 230000000844 anti-bacterial effect Effects 0.000 abstract 1
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 1
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/JP2000/005503 WO2002014338A1 (fr) | 2000-08-17 | 2000-08-17 | Nouveaux derives de pseudoerythromycine |
| EP00953461A EP1256587B1 (en) | 2000-08-17 | 2000-08-17 | Novel pseudoerythromycin derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1489090T3 true DK1489090T3 (da) | 2006-05-22 |
Family
ID=11736361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04022619T DK1489090T3 (da) | 2000-08-17 | 2000-08-17 | Hidtil ukendte pseudoerythromycinderivater |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US6734292B1 (da) |
| EP (2) | EP1489090B1 (da) |
| KR (6) | KR20040066184A (da) |
| AT (2) | ATE321770T1 (da) |
| AU (1) | AU2000265939A1 (da) |
| CA (1) | CA2386828C (da) |
| DE (2) | DE60027015T2 (da) |
| DK (1) | DK1489090T3 (da) |
| ES (2) | ES2257720T3 (da) |
| PT (1) | PT1489090E (da) |
| WO (1) | WO2002014338A1 (da) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7351834B1 (en) | 1999-01-13 | 2008-04-01 | Bayer Pharmaceuticals Corporation | ω-Carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| ATE538794T1 (de) | 1999-01-13 | 2012-01-15 | Bayer Healthcare Llc | Gamma carboxyarylsubstituierte diphenylharnstoffverbindungen als p38 kinasehemmer |
| US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
| WO2003068229A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
| MXPA04007832A (es) | 2002-02-11 | 2005-09-08 | Bayer Pharmaceuticals Corp | Aril-ureas con actividad inhibitoria de angiogenesis. |
| JP2003327536A (ja) * | 2002-03-07 | 2003-11-19 | Kitasato Inst:The | ヒト免疫不全症候群ウイルスの感染、増殖抑制剤 |
| US20040067896A1 (en) * | 2002-07-25 | 2004-04-08 | The Kitasato Institute | Novel pseudoerythromycin derivatives |
| US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
| WO2004113274A2 (en) | 2003-05-20 | 2004-12-29 | Bayer Pharmaceuticals Corporation | Diaryl ureas with kinase inhibiting activity |
| EA010485B1 (ru) | 2003-07-23 | 2008-10-30 | Байер Фамэсьютиклс Копэрейшн | Производное n,n'-дифенилмочевины, фармацевтическая композиция (варианты) и способ лечения и предупреждения заболеваний и состояний с его использованием (варианты) |
| US7229972B2 (en) * | 2004-12-07 | 2007-06-12 | Enanta Pharmaceuticals, Inc. | 3,6-Bicyclolides |
| US7419962B2 (en) * | 2004-12-07 | 2008-09-02 | Enanta Pharmaceuticals, Inc. | 3,6-bicyclolides |
| EP3290427A1 (en) | 2005-08-24 | 2018-03-07 | Melinta Therapeutics, Inc. | Triazole compounds and methods of making and using the same |
| CN101326192B (zh) * | 2005-10-14 | 2012-06-20 | 社团法人北里研究所 | 新型二氢伪红霉素衍生物 |
| US7407942B2 (en) * | 2006-03-29 | 2008-08-05 | Emata Pharmaceuticals, Inc | 3,6-bridged 9,12-oxolides |
| US8080645B2 (en) | 2007-10-01 | 2011-12-20 | Longhorn Vaccines & Diagnostics Llc | Biological specimen collection/transport compositions and methods |
| US9481912B2 (en) | 2006-09-12 | 2016-11-01 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and identifying nucleic acid sequences in biological samples |
| US8652782B2 (en) | 2006-09-12 | 2014-02-18 | Longhorn Vaccines & Diagnostics, Llc | Compositions and methods for detecting, identifying and quantitating mycobacterial-specific nucleic acids |
| US20090098527A1 (en) * | 2006-09-12 | 2009-04-16 | Fischer Gerald W | Biological organism identification product and methods |
| US8097419B2 (en) | 2006-09-12 | 2012-01-17 | Longhorn Vaccines & Diagnostics Llc | Compositions and method for rapid, real-time detection of influenza A virus (H1N1) swine 2009 |
| US11041215B2 (en) | 2007-08-24 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | PCR ready compositions and methods for detecting and identifying nucleic acid sequences |
| US9683256B2 (en) | 2007-10-01 | 2017-06-20 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system |
| US10004799B2 (en) | 2007-08-27 | 2018-06-26 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| AU2008293504B2 (en) | 2007-08-27 | 2012-04-12 | Longhorn Vaccines & Diagnostics, Llc | Immunogenic compositions and methods |
| US11041216B2 (en) | 2007-10-01 | 2021-06-22 | Longhorn Vaccines And Diagnostics, Llc | Compositions and methods for detecting and quantifying nucleic acid sequences in blood samples |
| CA2861667C (en) | 2007-10-01 | 2017-06-13 | Longhorn Vaccines And Diagnostics, Llc | Biological specimen collection and transport system and methods of use |
| JP5733601B2 (ja) * | 2010-07-13 | 2015-06-10 | 国立大学法人 千葉大学 | 劇症型炎症の予防および/または治療剤 |
| WO2013112916A1 (en) | 2012-01-26 | 2013-08-01 | Longhorn Vaccines And Diagnostics, Llc | Composite antigenic sequences and vaccines |
| WO2016183292A1 (en) | 2015-05-14 | 2016-11-17 | Longhorn Vaccines And Diagnostics, Llc | Rapid methods for the extraction of nucleic acids from biological samples |
| AU2022343476B2 (en) * | 2021-09-07 | 2025-02-20 | Zoetis Services Llc | Immunomodulating azalides |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1321581C (en) | 1987-05-26 | 1993-08-24 | Herbert A. Kirst | Ring-contracted macrolides |
| US5106961A (en) | 1987-05-26 | 1992-04-21 | Eli Lilly And Company | Erythromycin ring-contracted derivatives |
| US4920102A (en) * | 1988-04-18 | 1990-04-24 | Eli Lilly And Company | Method for treating gastrointestinal disorders |
| US5523401A (en) | 1991-04-09 | 1996-06-04 | Abbott Laboratories | Macrocyclic lactam prokinetic agents |
| CA2103913A1 (en) * | 1991-04-09 | 1992-10-10 | Leslie A. Freiberg | Macrocyclic lactam prokinetic agents |
| DE4200145A1 (de) | 1992-01-07 | 1993-07-08 | Kali Chemie Pharma Gmbh | 7,10-epoxy-oxacyclododecan-derivate, verfahren und zwischenprodukte zu ihrer herstellung und diese verbindungen enthaltende arzneimittel |
| DE19644195A1 (de) | 1996-10-24 | 1998-04-30 | Solvay Pharm Gmbh | 10,13,15-Trioxatricyclo[9.2.1.1.·9·.·6·]-pentadecanon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
| DE19805822B4 (de) | 1998-02-13 | 2009-02-05 | Solvay Pharmaceuticals Gmbh | 11-Acetyl-12,13-dioxabicyclo[8.2.1]tridecenon-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel |
-
2000
- 2000-08-17 AT AT00953461T patent/ATE321770T1/de not_active IP Right Cessation
- 2000-08-17 US US10/088,965 patent/US6734292B1/en not_active Expired - Fee Related
- 2000-08-17 AT AT04022619T patent/ATE316977T1/de not_active IP Right Cessation
- 2000-08-17 KR KR10-2004-7009825A patent/KR20040066184A/ko not_active Withdrawn
- 2000-08-17 DE DE60027015T patent/DE60027015T2/de not_active Expired - Fee Related
- 2000-08-17 WO PCT/JP2000/005503 patent/WO2002014338A1/ja not_active Ceased
- 2000-08-17 EP EP04022619A patent/EP1489090B1/en not_active Expired - Lifetime
- 2000-08-17 CA CA002386828A patent/CA2386828C/en not_active Expired - Fee Related
- 2000-08-17 KR KR10-2004-7009827A patent/KR20040066186A/ko not_active Withdrawn
- 2000-08-17 KR KR10-2004-7009828A patent/KR20040066187A/ko not_active Withdrawn
- 2000-08-17 ES ES04022619T patent/ES2257720T3/es not_active Expired - Lifetime
- 2000-08-17 KR KR10-2004-7009826A patent/KR20040066185A/ko not_active Withdrawn
- 2000-08-17 KR KR10-2004-7009829A patent/KR20040066188A/ko not_active Withdrawn
- 2000-08-17 EP EP00953461A patent/EP1256587B1/en not_active Expired - Lifetime
- 2000-08-17 KR KR10-2004-7009830A patent/KR20040074096A/ko not_active Withdrawn
- 2000-08-17 DE DE60025856T patent/DE60025856T2/de not_active Expired - Fee Related
- 2000-08-17 DK DK04022619T patent/DK1489090T3/da active
- 2000-08-17 PT PT04022619T patent/PT1489090E/pt unknown
- 2000-08-17 ES ES00953461T patent/ES2261224T3/es not_active Expired - Lifetime
- 2000-08-17 AU AU2000265939A patent/AU2000265939A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2386828C (en) | 2006-01-24 |
| EP1256587A1 (en) | 2002-11-13 |
| US6734292B1 (en) | 2004-05-11 |
| KR20040066188A (ko) | 2004-07-23 |
| AU2000265939A1 (en) | 2002-02-25 |
| PT1489090E (pt) | 2006-05-31 |
| ATE316977T1 (de) | 2006-02-15 |
| KR20040066184A (ko) | 2004-07-23 |
| ES2257720T3 (es) | 2006-08-01 |
| DE60027015D1 (en) | 2006-05-18 |
| KR20040066186A (ko) | 2004-07-23 |
| CA2386828A1 (en) | 2002-02-21 |
| ES2261224T3 (es) | 2006-11-16 |
| EP1489090A1 (en) | 2004-12-22 |
| ATE321770T1 (de) | 2006-04-15 |
| DE60027015T2 (de) | 2006-10-05 |
| WO2002014338A1 (fr) | 2002-02-21 |
| DE60025856T2 (de) | 2006-10-19 |
| EP1256587A4 (en) | 2004-01-28 |
| KR20040074096A (ko) | 2004-08-21 |
| KR20040066185A (ko) | 2004-07-23 |
| EP1489090B1 (en) | 2006-02-01 |
| DE60025856D1 (de) | 2006-04-13 |
| EP1256587B1 (en) | 2006-03-29 |
| KR20040066187A (ko) | 2004-07-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1489090T3 (da) | Hidtil ukendte pseudoerythromycinderivater | |
| ECSP045294A (es) | Derivados de 2,4-diaminopirimidina | |
| EA200400893A1 (ru) | N-арил-2-оксазолидинон-5-карбоксамиды, их производные и их применение в качестве антибактериальных средств | |
| UY26551A1 (es) | " agentes antibacterianos de 3-aminoquinazolin-2,4,dionas". | |
| HRP20080664A2 (hr) | Supstituirani piridinski herbicidi | |
| DK2314582T3 (da) | Heterocykliske forbindelser som antivirusmidler | |
| ES2182234T3 (es) | Inhibidores de metaloproteasa. | |
| DE60042762D1 (de) | Zwischenprodukte für die Herstellung von Harnstoffderivaten mit Muskarinrezeptor-antagonistischer Aktivität | |
| ES2172864T3 (es) | 2-metoxibenzofenonas fungicidas. | |
| CY1123488T1 (el) | Πεντακυκλοθειενυλο και ινδανυλο παραγωγα ουριας ως παραγοντες διανοιξης διαυλου καλιου | |
| UY27338A1 (es) | Nuevos derivados de ácido sulfónico | |
| MA27046A1 (fr) | Nouveaux derives d'oxazolidinones en tant qu'agents antibacteriens. | |
| ATE278661T1 (de) | Anthranilsäurederivate | |
| EP1671957A4 (en) | THIADIAZOLINDERIVATE | |
| DK1454903T3 (da) | Thiadiazolinderivater til behandling af cancer | |
| CO5680420A2 (es) | Compuestos de 6-amino-1h-indazol y 4-aminobenzenofurano como inhibidores de la fosfodiesterasa 4 | |
| BRPI0408675A (pt) | derivados de talidomida solúveis em água | |
| EA200400822A1 (ru) | Производные 3,4-дигидро-1h-изохинолин-2-ила | |
| ATE286887T1 (de) | Antibakterielle mittel | |
| EA200200838A1 (ru) | N-(гетероциклил)бензол- или пиридинсульфонамиды в качестве антитромботических агентов и антикоагулянтов | |
| ES2159489A1 (es) | Nuevos derivados de imidazol con actividad antiinflamatoria. | |
| BR0113978A (pt) | Derivados de tiazol de 2-metoxiimino-2-(piridiniloximetil)-fenil-acetamidas úteis como fungicidas | |
| BR0110328A (pt) | Compostos heterocìclicos com atividade antiinflamatória | |
| BR0210749A (pt) | Composições de fragrância e sabor | |
| DE60230924D1 (de) | 2-substituierte vitamin-d-derivate |